4//SEC Filing
Ragosa Mark 4
Accession 0001835458-26-000002
CIK 0001730430other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:35 PM ET
Size
5.4 KB
Accession
0001835458-26-000002
Insider Transaction Report
Form 4
Ragosa Mark
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Class A Ordinary Share
2026-01-08$41.89/sh−12,000$502,680→ 19,086 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.44 and $42.24. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001835458
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:35 PM ET
- Size
- 5.4 KB